Auranofin: Clinical Trials

1 trial of Auranofin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Terminated 1

Follow Auranofin: new trials by email Literature Review of Auranofin trials Research Report on Auranofin

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Auranofin and Sirolimus in Treating Participants With Ovarian Cancer
Auranofin, Laboratory Biomarker Analysis, Sirolimus - Ovarian Serous Tumor, Recurrent Ovarian Carcinoma
Phase 2TerminatedMayo Clinic222018-03-302025-05-08

Conditions studied

Ovarian Neoplasms (1)

Sponsors

Mayo Clinic (1)

Countries

United States (1)

Top investigators

Aminah Jatoi, M.D. (1)

Results publications

PMID 35254001, PMID 41114938